Annovis Bio, Inc. (ANVS)
2.33
+0.06
(+2.64%)
USD |
NYSE |
Apr 08, 12:08
Annovis Bio EPS Diluted (Quarterly) : -0.3964 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Avanos Medical, Inc. | -0.028 |
| Plus Therapeutics, Inc. | -1.03 |
| BioStem Technologies, Inc. | -0.67 |
| Iovance Biotherapeutics, Inc. | -0.1767 |
| Protokinetix, Inc. | -0.0002 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -9.834M |
| Total Expenses (Quarterly) | 9.834M |
| Enterprise Value | 44.83M |
| Earnings Yield | -62.30% |
| Normalized Earnings Yield | -62.73 |